Levitee Labs (OTC:LVTTF) Stock, Quote.Headers.trade-ideas

Levitee Labs Inc is a functional mushroom company, focused on developing and selling high-potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The company believes, based on a growing body of research, that mushrooms can be an effective way to enhance well-being and potentially treat various kinds of mental and physical health problems. The company's reportable segments are; the Medical services segment, which provides medical treatment; and the Selling products segment which is into buying and selling products. Substantial revenue is generated from Medical services operations.

Cannabis

News

Penny Stocks

Markets

CTABF

LVTTF

CSE:LVT

CSE:PILL

Wellness company Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE:7H7) confirmed Monday that it has teamed up with cannabinoid company Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F).

Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids

Small Cap

AGNPF

ALID

ATAI

AWKNF

BETRF

BMBIF

BRAXF

CLABF

CMPS

CYBN

DELCF

DMTTF

EHVVF

ENTBF

ENVB

FLHLF

FTRP

GHRS

GTSIF

HAVLF

HSTRF

IGXT

KONEF

KTTA

LKYSF

LMLLF

MCURF

MNMD

MSSTF

MYNDF

NMDBF

NMLSF

NVMDF

OPTHF

PHRRF

PSIL

PSYBF

PSYCF

RVVTF

SEEL

SILFF

SILO

TRIP

TRYPF

VEGGF

WSNAF

WUHN

MYCFO

CSE:PHRM

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai&#39;s New Subsidiary, PharmaTher Gets New Orphan Drug Designation

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are

Levitee Labs Inc

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $128 price target.

Price Target

Analyst Ratings

BMEA

D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $128 Price Target

B of A Securities analyst Tim Anderson reinstates Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Underperform and announces $41 price target.

Initiation

MRNA

B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target

The gross proceeds, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $40 million. The offering is expected to close on or about December 11, 2024, subject to the satisfaction of customary closing conditions.
 &nbsp;

Offerings

CRDF

Cardiff Oncology Reports Pricing Of Offering Of 15.38M Shares Of Its Common Stock At $2.60 Per Share

Heightened geopolitical tensions and Homeland Security concerns call for the development of potential therapies that can be quickly and easily mobilized in the event of a mass casualty nuclear or radiological incident
There are currently no known approved therapies for gastrointestinal acute radiation syndrome (GI-ARS)
Positive results from new in vivo studies of opaganib as a treatment for GI-ARS, undertaken as part of the U.S. government's Radiation and Nuclear Countermeasures Program (RNCP)&nbsp;product pipeline development contract, further confirm opaganib's protective activity
Discussions now ongoing with the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID), which leads the RNCP, regarding plans for the next phase of development along the U.S. Food and Drug Administration's (FDA) Animal Rule pathway to approval

RDHL

RedHill Biopharma's Opaganib Demonstrates Protective Activity Against GI-ARS, Paving The Way for Future FDA Approval vVa Animal Rule

The year 2024 has been a standout for U.S. air travel, breaking records across key travel periods. Spring break, summer vacations and Thanksgiving all saw unprecedented levels of air travel, with over 4.7 million Americans flying during the Thanksgiving holiday alone – up 6.6% from 2023. These surges occurred despite a 25% increase in airfare costs reported by CNBC, highlighting a curious disconnect between rising travel demand and ongoing complaints about economic challenges like expensive eggs and gas.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
Record Air Travel Throughout 2024
According to the Transportation Security Administration (TSA), 2024 saw record-breaking flight volumes in multiple travel seasons. The spring break period alone logged the highest passenger counts in history, bolstered by strong international and domestic demand, with summer travel continuing the trend. These patterns culminated in a historic Thanksgiving travel season, cementing 2024 as a <a href="https://www.benzinga.com/startups/24/12/42316033/just-4-airlines-control-80-of-the-industry-how-a-small-airport-in-montana-is-fighting-back-against-skyrocketing-prices">landmark year for the airline industry</a>.
This sustained growth suggests Americans were willing to prioritize travel despite rising costs. While airfare prices climbed 25%, driven by higher operational costs and demand, travel&#8217;s emotional and practical value outweighed financial concerns for many.
See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Eggs, Gas and Public Perception
Complaints about elevated <a href="https://www.benzinga.com/personal-finance/24/10/41250565/trump-and-dave-ramsey-break-down-8-eggs-5-gas-and-7-interest-rates-can-anyone-afford-a-house-in-">egg prices and fluctuating gas costs</a> reveal a deeper tension between everyday expenses and planned, high-value expenditures like travel. Eggs, a grocery staple, remained expensive due to supply chain disruptions, affecting household budgets. Meanwhile, gas prices were at their lowest Thanksgiving levels since 2020, averaging $3.07 per gallon. This drop in fuel costs relieved the 55.4 million Americans who traveled by car during the holiday.
However, these frustrations were eclipsed by a broader willingness to spend on travel. Planned expenses like flights are often viewed as investments in experiences, making them less likely to be sacrificed during inflationary periods.
Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Why Air Travel Persisted
<ol>
<li>Emotional Priorities: Family gatherings remained a cornerstone of holiday traditions, with Americans willing to absorb higher costs to maintain connections. TSA officials noted that this enduring desire drove the Thanksgiving travel season. </li>
<li>Economic Strategies: Travelers adapted through early bookings, loyalty programs and credit card rewards. Despite higher ticket prices, financial planning made air travel accessible for many. </li>
<li>Recovery and Growth: Rising wages and improved employment rates in 2024 enabled households to better manage inflation, encouraging discretionary spending on travel. </li>
<li>Convenience and Time Savings: Flying&#8217;s time-efficient nature continued to appeal to travelers, especially during holiday seasons when time with family is at a premium.</li>
</ol>
Despite frustrations over rising costs for everyday goods, 2024's record-breaking air travel also reflects a reality often overlooked: some of the most visible complaints, like egg and gas prices, have not risen as dramatically since 2020 as they might seem. For example, while egg prices spiked during the avian flu outbreak in late 2022 and early 2023, they stabilized in 2024, with the average cost of a dozen eggs settling at around $2.20 – a modest increase from pre-pandemic prices of approximately $1.92 in 2020​.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Similarly, gas prices for Thanksgiving 2024 averaged $3.07 per gallon, marking the lowest level since 2020 when prices hovered near $2.10 during the pandemic's economic slowdown. Although this reflects an increase from 2020 lows, it is still well below the peak in 2022, when prices surged past $5 per gallon in some areas.​
These trends show that while consumers may feel the weight of inflation in other areas, key categories like eggs and gas have not risen disproportionately compared to broader economic conditions. This moderation in cost increases helped many Americans prioritize travel and family gatherings, underscoring the resilience of traditions and the evolving perception of financial burdens over time.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Were Expensive Eggs and Gas The Real Issue When U.S. Air Travel Hit Record Levels in 2024, Despite a 25% Inflation in Airline Ticket Prices?

NAMSW

Trading Halt: Halt status updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times

B of A Securities analyst Tim Anderson reinstates Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) with a Underperform and announces $256 price target.

AMGN

B of A Securities Reinstates Underperform on Amgen, Announces $256 Price Target

BTTR

Better Choice Company Boosts Halo Capital Stock Distribution Fom 8% To 17% As Part Of SRx Health Acquisition

B of A Securities analyst Tim Anderson reinstates Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Buy and announces $121 price target.

B of A Securities Reinstates Buy on Merck & Co, Announces $121 Price Target

The company also announced its initial order of over 110 megawatts of mobile natural gas-fueled power generation equipment for use across multiple oilfield and industrial applications.
This growth capital investment of approximately $122 million will be funded through a combination of cash and external financing resources with equipment deliveries anticipated to take place between June 2025 and March 2026.&nbsp;
The cash investment will consist of up to approximately $20 million in early 2025 with the remaining cost of the investment expected to be financed as progress payments become due and deliveries ultimately occur commencing mid-2025.&nbsp;
&nbsp;

PUMP

ProPetro Holding Announces New Subsidiary, ProPetro Energy Solutions, That Will Do Business As ProPWR

NAMS

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) with a Buy and maintains $10 price target.

Reiteration

AFMD

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $10 Price Target

B of A Securities analyst Tim Anderson reinstates Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Buy and announces $109 price target.

GILD

B of A Securities Reinstates Buy on Gilead Sciences, Announces $109 Price Target

TRNR

Interactive Strength Regains Nasdaq Compliance With Listing Standards, Secures Continued Listing Eligibility

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday.
Shares of Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) fell sharply in today's pre-market trading after reporting <a href="https://www.benzinga.com/quote/YEXT">third-quarter results</a>.
Yext reported quarterly earnings of 12 cents per share which met the analyst consensus estimate. The company reported quarterly sales of $114.000 million which beat the analyst consensus estimate of $113.208 million.
Yext shares dipped 10.8% to $7.60 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Huize Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUIZ#NASDAQ">HUIZ</a>) shares fell 18.4% to $4.93 in pre-market trading after reporting third-quarter results.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) shares dipped 18.4% to $7.42 in pre-market trading after dipping 51% on Monday.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) shares dipped 9.4% to $7.04 in pre-market trading after jumping 26% on Monday.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) shares fell 8.8% to $16.90 in pre-market trading. The company announced a senior convertible notes offering amounting to $300 million with an option for an additional $45 million.</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) shares fell 8.5% to $21.24 in pre-market trading.</li>
<li>HarborOne Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) shares fell 7.8% to $12.00 in pre-market trading.</li>
<li>Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) shares dipped 7.2% to $176.80 in pre-market trading as the company posted weaker-than-expected earnings and sales results for its second quarter.</li>
<li>HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) fell 6% to $95.00 in pre-market trading after the company reported worse-than-expected third-quarter sales results.</li>
<li>Lufax Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LU#NASDAQ">LU</a>) declined 5.5% to $2.76 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42405361/sp-500-nasdaq-retreat-from-record-highs-investor-sentiment-declines-fear-greed-index-remains-in-neutral-zone">S&amp;P 500, Nasdaq Retreat From Record Highs As Nvidia Declines Over Chinese Antitrust Concerns: Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Movers

Trading Ideas

BILI

FLNC

HONE

HUIZ

ORCL

RADX

TIGR

YEXT

Yext, Oracle, Huize Holding And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

B of A Securities analyst Tim Anderson reinstates Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Buy and announces $997 price target.

B of A Securities Reinstates Buy on Eli Lilly, Announces $997 Price Target

ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) stock rose 1% in premarket hours on Tuesday after a Dutch court extended the detention of a former Russian employee of the semiconductor equipment maker, suspected of stealing intellectual property and selling it to Russian buyers.
However, technical analysis using simple moving averages suggests that the stock price is neither increasing nor decreasing but oscillating within a defined range.
What Happened: The 43-year-old man named German Aksenov is suspected of stealing proprietary design manuals related to microchips, microchip equipment, and military-grade technology from ASML, Mapper, NXP, and the Delft University of Technology,
Aksenov, arrested on Aug. 28, has denied all charges and remains in custody. Prosecutors requested an extension of his detention until February, citing the risk of flight and potential further leaks, according to Reuters.
See Also: <a href="https://www.benzinga.com/analyst-ratings/upgrades/24/12/42407670/sofi-technologies-shares-fall-after-bofa-downgrade-over-valuation-concerns">SoFi Stock Falls After BofA Downgrade Over Valuation Concerns: Here&#8217;s What Technical Analysis Shows</a>
Why It Matters: Shares of ASML Holding have declined by 1.45% on a year-to-date basis and 32.18% in the last six months. This compares to a 29.6% and 12.4% growth in the Nasdaq 100 Index in the same period, respectively.
From a technical perspective, the analysis of daily moving averages indicates a potential period of consolidation.
Shares were trading at $709.56 apiece in premarket, which was above its eight and 20-day simple moving averages, of $709.06 apiece and $686.08 per share, respectively. As per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data, its current stock price was lower than the 50 and 200-day moving average prices at $719.23 apiece and $880.62 per share, respectively.
This trend indicates that the stock is experiencing near-term upward momentum but it is still broadly below its longer-term price movement, indicating consolidation. On the other hand, the relative strength index of 54.09 suggests the stock was in the neutral region, neither overbought nor oversold.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings-1024x576.png" alt="" class="wp-image-684980" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062706/ASML-Holdings.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/24/12/42405749/bitcoin-far-more-of-a-threat-than-a-brics-reserve-currency-says-jeremy-siegel-find-it-curious-that-trump-championed-btc-at-100k" target="_blank" rel="noreferrer noopener">Bitcoin Far More Of A Threat Than A BRICS Reserve Currency, Says Jeremy Siegel: Find It ‘Curious' That Trump Championed BTC At 100K</a>
What Analysts Are Saying: According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>, ASML has a consensus price target of $870 per share based on the ratings of 13 analysts. The highest price target out of all the <a href="https://www.benzinga.com/quote/ASML/analyst-ratings">analysts tracked by Benzinga</a> is $1,148 apiece issued by JPMorgan in October.
The average price target of $790.67 apiece between two changes from Bernstein, and Wells Fargo implies an 11.9% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/ASML/analyst-ratings"><img loading="lazy" decoding="async" width="951" height="355" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062814/ASML-Holdinsg-ANR.png" alt="" class="wp-image-684981" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062814/ASML-Holdinsg-ANR.png 951w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062814/ASML-Holdinsg-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10062814/ASML-Holdinsg-ANR-768x287.png 768w" sizes="(max-width: 951px) 100vw, 951px" /></a></figure>
Read Next:
<ul>
<li><a href="http://trump's%20deregulation%20efforts%20to%20benefit%20energy,%20oil%20and%20gas%20sectors,%20while%20ai%20frenzy%20will%20boost%20faang%20stocks%20and%20nvidia,%20says%20fintech%20insider/" target="_blank" rel="noreferrer noopener">Trump&#8217;s Deregulation Efforts To Benefit Energy, Oil And Gas Sectors, While AI Frenzy Will Boost FAANG Stocks And Nvidia, Says Fintech Insider</a></li>
</ul>
Photo courtesy: ASML

Equities

Legal

Global

Tech

ASML

ASML Stock Edges Up In Premarket After Dutch Court Detains Military Grade IP Theft Suspect Till February

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) with a Buy and maintains $115 price target.

ACLX

HC Wainwright & Co. Reiterates Buy on Arcellx, Maintains $115 Price Target

JPMorgan-Owned Subsidiaries PricingDirect And Aumni Team Up To Deliver Independent Valuations For Private Equity Investors

Contracts

Mobilicom Secures Its Latest Initial Production-scale Orders For Its Cybersecure SkyHopper Pro Datalinks From US-based Drone Designer And Manufacturer

Levitee Labs

Comments

Levitee Labs

Levitee Labs (LVTTF) Forecast

Levitee Labs (OTC:LVTTF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga